Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease

A major concern in the management of Inflammatory Bowel Disease (IBD) is the absence of accurate and specific biomarkers to drive diagnosis and monitor disease status timely and non-invasively. Fibroblast activation protein (FAP) represents a hallmark of IBD bowel strictures, being overexpressed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsi, Fabio, Sorrentino, Luca, Albasini, Sara, Colombo, Francesco, Cigognini, Maria, Massari, Alessandro, Morasso, Carlo, Mazzucchelli, Serena, Piccotti, Francesca, Ardizzone, Sandro, Sampietro, Gianluca M., Truffi, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490650/
https://www.ncbi.nlm.nih.gov/pubmed/34621763
http://dx.doi.org/10.3389/fmed.2021.725726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490650/
https://www.ncbi.nlm.nih.gov/pubmed/34621763
http://dx.doi.org/10.3389/fmed.2021.725726

Ejemplares similares